x

Breast Cancer

Stethoscope closeup (Photo Courtesy: wenzday via Flickr)
Seed Grants Fund Foundational Work on Diseases Disproportionately Affecting Black Americans

An illustration of improved delivery of anti-cancer drugs to malignancies in the brain. On the left half, focused ultrasound agitates microbubbles, which breach the blood-brain barrier, allowing drug molecules to get through. The forces also stir interstitial fluid to circulate the drug, and they also encourage the drug to cross cell membranes more easily into tumor cells. Credit: Massachusetts General Hospital / Georgia Tech / Arvanitis / Askoxylakis
Buzzing Cancer Drugs into Malignancies in the Brain

As a new anti-cancer drug delivery method heads into phase I clinical trials, researchers explore the tissue-level mechanisms that make it work.
Georgia Tech/Emory University biomedical engineering associate professor Manu Platt (standing) and graduate student Keon-Young Park examine gels that display the activity levels of cathepsins, which are protein-degrading enzymes. In a new study, the researchers are studying levels of cathepsins and other signaling chemicals in an effort to predict the invasiveness of breast cancer in individual patients. (Credit: Gary Meek, Georgia Tech)
Predictive Model Could Help Guide Choices for Breast Cancer Therapies

A new technique could give women and their oncologists more personalized information for choosing breast cancer treatment options.